Axi-Cel Shows Favorable Outcomes in Large B-Cell Lymphoma Regardless of Race, Ethnicity
[ad_1] In patients with large B-cell lymphoma (LBCL), treatment with axicabtagene ciloleucelย (axi-cel;Yescarta; Kite Pharma, Gilead) was associated with a favorable overall survival (OS), progression free survival (PFS), and safety profile […]
Axi-Cel Shows Favorable Outcomes in Large B-Cell Lymphoma Regardless of Race, Ethnicity Read More ยป




















